US Patent Issued to The Cleveland Clinic Foundation on July 15 for "Methods of treating spinal cord injury using a supressor of cytokine signaling-3 (SOCS3) reduction peptide (SRP) comprising a cell membrane penetrating domain, a SOCS3 binding domain, and a lysosome targeting domain" (Ohio Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,961, issued on July 15, was assigned to The Cleveland Clinic Foundation (Cleveland).

"Methods of treating spinal cord injury using a supressor of cytokine signaling-3 (SOCS3) reduction peptide (SRP) comprising a cell membrane penetrating domain, a SOCS3 binding domain, and a lysosome targeting domain" was invented by Yu-Shang Lee (Solon, Ohio) and Ching-Yi Lin (Solon, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions, systems, kits, and methods for treating nervous system injuries caused by trauma or neurodegeneration or aging in a subject by administering a CSPG or SOCS3 reduction peptide (CRP and SRP respectively...